Share this post on:

Mation, acute expression of Rae-1 resulted within a nearby immune reorganization. Within 120 h of doxycycline therapy, each Langerhans cells and DETCs exhibited adjustments in morphology and activation markers. The effect on DETCs morphology is unsurprising offered that these cells express NKG2D and that engagement of NKG2D results in the downstream activation of Vav-1, which has a vital function in controlling NK cell cytoskeletal IL-12 Inhibitor Storage & Stability polarization (113). Nevertheless, Langerhans cells usually do not express NKG2D, and their response to Rae-1 expression is likely indirect, probably due to cytokines induced by NKG2D-mediated activation of DETCs in the tissue. Importantly, transient NKG2D ligand expression will not generally induce effector cell-mediated cytotoxicity. NKG2D-mediated crosstalk involving NK cells and dendritic cells (DC) in the course of viral infection has been recommended to augment NK cell responses (68,114,115). To investigate the impact of NKG2D ligand expression in many cell populations, we have recently generated a knock-in mouse in which a LoxP-stop-LoxP Rae-1 cassette was inserted in to the Rosa26 locus. Crossing this mouse to different tissue- or cell-restricted Cre recombinase will allow restricted Rae-1 expression into a place of interest. In specific, we’re at the moment investigating the effects of DC-restricted expression of Rae-1 to explore the crosstalk involving DC and NK cells through viral infections. Chronic response to membrane-bound NKG2D ligands Despite the efficient eradication of cells that express NKG2D ligands transiently, constitutive ligand expression has been shown to impair NKG2D function in humans and mice. This observation was IL-12 Activator site initially reported by Groh et al. who analyzed tumor-infiltrating lymphocytes (TILs) from human epithelial tumors (116). Presence of MICA on tumor cells consistently correlated with decreased NKG2D levels on NK cells and CD8+ T cells and impaired NKG2Dmediated IFN- production by CD8+ T cells. Subsequently, many groups described similarly impaired NKG2D function in individuals with NKG2D ligand-expressing tumors (11719). Ligand-induced downregulation of the NKG2D receptor was also described by Ogasawara et al. in NOD mice (120). When NK cells from NOD mice had been activated by IL-2, the NK cells then themselves expressed NKG2D ligands, which in turn downregulated their expression of NKG2D receptor and impaired its function. In addition, when NK cells from C57BL/6 mice were co-cultured in vitro with tumor cells expressing NKG2D ligands, this once again resulted in the down-modulation of NKG2D around the NK cells and impaired their NKG2D-dependent functions (120,121). Subsequently, quite a few mouse models happen to be constructed to get further understanding around the effect of sustained NKG2D engagement on receptor function (Table 1). To separate ligand expression from any other aspect of tumorigenesis or inflammation, most models developed have expressed a NKG2D ligand beneath a ubiquitous promoter in an otherwise normal mouse. Within the majority of instances, these transgenic mice developed generally, and exhibited no sign of autoimmunity. One particular exception comes from a study in which a MICB transgene was driven by a ubiquitous promoter (122). These mice exhibited a 50 increase within the quantity of white blood cells, plus a ten to 20 reduction in physique weight in comparison to their littermate manage. In addition, transient exfoliation on the skin was observed at a young age. This study suggests an involvement of human MICB in skin inflammation, however it didn’t in.

Share this post on: